75_1_87.pdf 2.5 MB
Shiotani, Toshio Department of Organ Transplant Center, Okayama University Hospital
Sugimoto, Seiichiro Department of Organ Transplant Center, Okayama University Hospital ORCID Kaken ID publons researchmap
Araki, Kota Department of General Thoracic Surgery, Okayama University Hospital
Tomioka, Yasuaki Department of Organ Transplant Center, Okayama University Hospital
Miyoshi, Kentaroh Department of General Thoracic Surgery, Okayama University Hospital Kaken ID
Otani, Shinji Department of General Thoracic Surgery, Okayama University Hospital
Yamane, Masaomi Department of General Thoracic Surgery, Okayama University Hospital Kaken ID researchmap
Although chronic kidney disease (CKD) commonly develops after lung transplantation (LT), living-donor kid-ney transplantation (LDKT) for CKD after LT is known to provide favorable outcomes. We describe the long-term follow-up findings of a patient who underwent LDKT after bilateral cadaveric LT. A 37-year-old male underwent LDKT for CKD 18 years after receiving bilateral cadaveric LT. He developed chronic lung allograft dysfunction (CLAD) 20 years after the LT; however, at 26 years after the initial LT, he is still alive with no pro-gression of CLAD or CKD. KT could be a viable option for CKD even after LT in Japan.
chronic kidney disease
non-tuberculous mycobacterial infection
chronic lung allograft dysfunction
Acta Medica Okayama
Okayama University Medical School
CopyrightⒸ 2021 by Okayama University Medical School
Chambers DC, Cherikh WS, Harhay MO, Hayes D, Jr., Hsich E, Khush KK, Meiser B, Potena L, Rossano JW, Toll AE, Singh TP, Sadavarte A, Zuckermann A and Stehlik J: The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipi-ent size match. J Heart Lung Transplant (2019) 38: 1042-1055.
Sugimoto S, Yamamoto H, Kurosaki T, Otani S, Okazaki M, Yamane M, Toyooka S and Oto T: Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience. Surg Today (2019) 49: 686-693.
Bloom RD and Doyle AM: Kidney Disease After Heart and Lung Transplantation. Am J Transplant (2006) 6: 671-679.
Hirano Y, Sugimoto S, Mano T, Kurosaki T, Miyoshi K, Otani S, Yamane M, Kobayashi M, Miyoshi S and Oto T: Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation. Ann Transplant (2017) 22: 484-492.
Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L and Merion RM: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 349: 931-940.
Otani S, Levvey BJ, Westall GP, Paraskeva M, Whitford H, Williams T, McGiﬃn DC, Walker R, Menahem S and Snell GI: Long-term successful outcomes from kidney transplantation after lung and heart-lung transplantation. Ann Thorac Surg (2015) 99: 1032-1038.
Shimizu N, Aoe M, Date H, Yamashita M, Sano S and Tanemoto K: Bilateral lung transplantation in a Japanese adolescent with pri-mary pulmonary hypertension. J Jpn Assoc Chest Surg (1995) 9: 546-550.
Toyooka S, Waki N, Okazaki M, Kato K, Yamane M, Oto T, Sano Y and Date H: Recurrent lung cancer in the mediastinum noticed after a living-donor lobar lung transplantation. Ann Thorac Cardiovasc Surg (2009) 15: 119-122.
Luo K, Lim SW, Quan Y, Cui S, Shin YJ, Ko EJ, Chung BH and Yang CW: Role of Klotho in Chronic Calcineurin Inhibitor Nephropathy. Oxid Med Cell Longev (2019) 2019: 1825018.
Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G and Vos R: Chronic lung allograft dysfunction: Deﬁnition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant (2019) 38: 493-503.
Sugimoto S, Miyoshi K, Kurosaki T, Otani S, Yamane M, Kobayashi M and Oto T: Favorable survival in lung transplant recipients on preoperative low-dose, as compared to high-dose corticosteroids, after hematopoietic stem cell transplantation. Int J Hematol (2018) 107: 696-702.
Suzuki H, Matsuda Y, Noda M, Oishi H, Watanabe T, Sado T, Yamada M, Tamada T and Okada Y: Management of De Novo Mycobacterial Infection After Lung Transplantation Without Rifampicin: Case Series of a Single Institution. Transplant Proc (2018) 50: 2764-2767.
Sugimoto S, Yamane M, Otani S, Kurosaki T, Okahara S, Hikasa Y, Toyooka S, Kobayashi M and Oto T: Airway complications have a greater impact on the outcomes of living-donor lobar lung trans-plantation recipients than cadaveric lung transplantation recipients. Surg Today (2018) 48: 848-855.
Delmonico F: A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation (2005) 79: S53-S66.